Connect with us

National

Tiny device could be the new way to treat rheumatoid arthritis


A device the size of a 50 cent coin could be a new way to treat rheumatoid arthritis.

It’s a condition affecting almost half a million Australians each year.

Many are treated with a range of drugs to stop the pain and stiffness.

Now researchers at the Bionics Institute have developed a treatment that could be an alternative to medication

READ MORE: Fears exclusive Melbourne Cup party is a ‘super spreader’ event

A device the size of a 50 cent coin could be a new way to treat rheumatoid arthritis.

The battery-powered device is implanted below the lungs in an abdominal cavity.

It stimulates the vagus nerve, a major nerve in the body, the electricity is thought to reboot the body’s built-in healing system.

Dr Sophie Payne from the Bionics Institute said “it basically uses your own bodies natural way of fighting-off inflammation.”

Advertisement

In rheumatoid arthritis, the body attacks its own joints causing inflammation, pain and stiffness.

“By stimulating the vagus nerve, which controls the body’s anti-inflammatory reflex, we can dampen the inflammation to reduce the pain and stiffness and allow people with rheumatoid arthritis to move freely,” Dr Payne said.

READ MORE: Aussie victims sent bizarre items in the post

A device the size of a 50 cent coin could be a new way to treat rheumatoid arthritis.A device the size of a 50 cent coin could be a new way to treat rheumatoid arthritis.

Karen Morgan has lived with rheumatoid arthritis for 22 years.

“You feel tired, when things get sore they not only get sore they get stiff,” Ms Morgan said.

“The medication makes the pain bearable most of the time, but when I have a flare up it’s a struggle to do anything.”

READ MORE: Swooping crows with ‘grudges’ terrorise Gold Coast shopping district

A device the size of a 50 cent coin could be a new way to treat rheumatoid arthritis.

Similar devices have been trialled overseas but implanted in the neck.

Some patients have reported coughing, a hoarse voice and in some cases the slowing of the heart.

“I’ll be more beneficial because we are applying the electricity below the branches that activate the heart and the lungs,” Dr Payne said.

Advertisement

Once funding is secured trials are expected to begin in two years.



Source link